Biocon Ltd buy melinda
Start price
07.09.17
/
50%
?2.26
Target price
30.11.17
€3.25
Performance (%)
23.78%
End price
30.11.17
€2.80
Summary
This prediction ended on 30.11.17 with a price of €2.80. The BUY prediction by melinda finished with a performance of 23.78%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocon Ltd | - | - | - | - |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% | 57.692% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% | 83.804% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% | 56.282% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% | 57.791% |
Comments by melinda for this prediction
In the thread Biocon Ltd diskutieren
Biotechnologie und Medizintechnik
Biocon sagt die Insuline in Malaysia ein EU - GMP - Konformitätszertifikat erhalten
7. September (Reuters) - Biocon Ltd Biocon Insulin Institutionen in Malaysia erhalten eine EU - GMP - Konformitätsbescheinigung